ClinicalTrials.govpublic full text
Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit
covid19, sars (severe acute respiratory syndrome), proxalutamide, androgen, anti-androgen, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 902346
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.